| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.06 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.065 | 0.06 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.09 | 0.06 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.07 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.069 | 0.07 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.083 | 0.07 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.058 | 0.07 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.07 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.07 |